Brought to you by 
Smith & Nephew acquires Nucryst for $28mm
Jan 2010
Executive Summary
Smith & Nephew Advanced Wound Management has closed its acquisition of Nucryst Pharmaceuticals, a public company with wound care products and pharmaceuticals based on a nanocrystalline silver technology. S&N paid $21mm in cash plus other working capital adjustments of $7mm.
Deal Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Smith & Nephew acquires Nucryst for $28mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice